Emergent Biosolutions Inc (EBS)
R&D Expenses
$45.30M
TTM · Period ending: · USD
EBS R&D Expenses
Latest reported$45.30Mperiod ending
Latest reported$45.30Mperiod ending
EBS R&D Expenses ($193.00M → $45.30M)
Annual R&D Expenses
High-resolution chart · PNG
EBS r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 53,800,000 | |
| 70,700,000 | |
| 111,400,000 | |
| 188,300,000 | |
| 235,200,000 | |
| 237,900,000 | |
| 226,200,000 | |
| 142,800,000 | |
| 97,400,000 | |
| 106,900,000 | |
| 119,186,000 | |
| 104,721,000 | |
| 119,933,000 | |
| 129,826,000 | |
| 124,832,000 | |
| 89,295,000 | |
| 74,588,000 | |
| 59,470,000 | |
| 53,958,000 | |
| 45,501,000 | |
| 18,381,000 | |
| 10,117,000 | |
| 0 | |
| 2,808,000 | |
| 193,000,000 |